Stephen J Luen

6PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersAboriginal and Torres Strait Islander mothers and babies health and wellbeingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 03, 2026
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer.

Soraia Lobo-Martins, Stephen J Luen, Martine Piccart

|Apr 29, 2025
Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer.

Alice R T Bergin, Luc Te Marvelde, Roger L Milne

|Feb 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.

Valentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz

|Jun 30, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study.

Peter Savas, Louisa L Lo, Stephen J Luen

|Jan 07, 2022
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.

Angela Mweempwa, Huiling Xu, Joseph H A Vissers

|Mar 01, 2020
Tissue-resident memory T cells in breast cancer control and immunotherapy responses.

Ann Byrne, Peter Savas, Sneha Sant

Pageof 1